Li Wenjing, Hou Lingfei, Hua Zhaowei, Wang Xian
Institute of Vascular Medicine, Peking University Third Hospital, Beijing 100083, P. R. of China.
FASEB J. 2004 Oct;18(13):1603-5. doi: 10.1096/fj.04-1737fje. Epub 2004 Aug 19.
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide mainly present in sensory nerve fibers, which is present in almost all organs, but it is also found in cultured rat type II alveolar epithelial cells (AEII). Our data have previously shown that CGRP may play an important role in inflammation as an immunomodulator. Proinflammatory factor IL-1beta induces CGRP release from neuron-derived sources. However, whether IL-1beta can induce CGRP secretion from a nonneural source, AEII cells, is not known. In the present study, we demonstrated that human AEII A549 cells expressed beta-CGRP, and IL-1beta (0.001-50 ng/ml) directly increased CGRP secretion from these cells in a time- and concentration-dependent manner. The mRNA level of beta-CGRP was also elevated by IL-1beta (1 ng/ml). In addition, we found that IL-1beta-induced CGRP production was mediated through the PKC-p38 mitogen-activated protein (MAP) kinase-NF-kappaB signaling pathway. Furthermore, IL-1beta-induced chemokines MCP-1 and IL-8 were partially inhibited by exogenous hCGRP (0.1-10 nM) and potentiated by hCGRP8-37 (0.1-10 nM), a CGRP1-receptor antagonist. In addition, the CGRP-inhibited chemokine effect was partially reduced by Rp-cAMP, a cAMP-PK inhibitor. These results suggest that AEII-derived CGRP may act in an autocrine/paracrine mode and play an important inhibitory role in the local area in lung inflammatory diseases.
降钙素基因相关肽(CGRP)是一种由37个氨基酸组成的神经肽,主要存在于感觉神经纤维中,几乎存在于所有器官中,但在培养的大鼠II型肺泡上皮细胞(AEII)中也有发现。我们之前的数据表明,CGRP作为一种免疫调节剂可能在炎症中发挥重要作用。促炎因子IL-1β可诱导神经元来源释放CGRP。然而,IL-1β是否能诱导非神经来源的AEII细胞分泌CGRP尚不清楚。在本研究中,我们证明人AEII A549细胞表达β-CGRP,并且IL-1β(0.001 - 50 ng/ml)以时间和浓度依赖性方式直接增加这些细胞的CGRP分泌。IL-1β(1 ng/ml)也使β-CGRP的mRNA水平升高。此外,我们发现IL-1β诱导的CGRP产生是通过蛋白激酶C - p38丝裂原活化蛋白(MAP)激酶 - 核因子κB信号通路介导的。此外,外源性hCGRP(0.1 - 10 nM)部分抑制了IL-1β诱导的趋化因子MCP-1和IL-8,而CGRP1受体拮抗剂hCGRP8-37(0.1 - 10 nM)则增强了它们的作用。此外,cAMP - PK抑制剂Rp - cAMP部分降低了CGRP对趋化因子的抑制作用。这些结果表明,AEII来源的CGRP可能以自分泌/旁分泌模式发挥作用,并在肺部炎症性疾病的局部区域发挥重要的抑制作用。